Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin

Steve Stegen; Ingrid Stockmans; Karen Moermans; Bernard Thienpont; Patrick H. Maxwell; Peter Carmeliet; Geert Carmeliet

doi:10.1038/s41467-018-04679-7

Related publications

Article2025

Lactate controls cancer stemness and plasticity through epigenetic regulation

Nguyen T.B. Nguyen, Sira Gevers, Rutger N.U. Kok, Lotte M Burgering, Hannah K. Neikes, Ninouk Akkerman, Max A. Betjes, Marlies C. Ludikhuize, Can Gulersonmez, Edwin C.A. Stigter, Yvonne Vercoulen, Jarno Drost, Hans Clevers, Michiel Vermeulen, Jeroen S. van Zon, Sander J. Tans, Boudewijn Burgering, Maria J. Rodríguez Colman

Article2015

Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength

Weimin Yao, Weiwei Dai, Li Jiang, Evan Yu-An Lay, Zhendong Zhong, Robert O. Ritchie, X. Li, Hua Zhu Ke, N.E. Lane

Osteoporosis International

Article2012

Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis

Jayasri Nanduri, Vladislav Makarenko, Vaddi Damodara Reddy, Guoxiang Yuan, Anita Pawar, Ning Wang, Shakil A. Khan, Xin Zhang, Brian Kinsman, Yingjie Peng, Ganesh K. Kumar, Aaron P. Fox, Lucy A. Godley, Gregg L. Friedman, Nanduri R. Prabhakar

Article2015

Regulation of carotid body oxygen sensing by hypoxia-inducible factors

Nanduri R. Prabhakar, Gregg L. Friedman

Article2012

Sclerostin: a possible target for the management of cancer-induced bone disease

Μαρία Γκοτζαμανίδου, Meletios A Dimopoulos, Efstathios Kastritis, Dimitrios Christoulas, Lia A. Moulopoulos, Evangelos Terpos